Relation of erectile dysfunction to coronary artery disease

Although the incidence and severity of erectile increases with age, the most common pathologic risk factor for dysfunction is to be diabetes. Erectile occasion to be governed by on nitric oxide fabrication by nerves and on arteriolar smooth force leisure. Penile conduit flow is conditional on vascular endothelial gathering that is compromised by other risk for cardiovascular syndrome including hyperlipidemia, smoking, and hypertension. Endothelial can mark from these disorders and can steps forward to atherosclerosis. To estimate the correspondence between dysfunction severity and the degree of coronary artery sickness, Solomon and associates studied the presence and severity of erectile in a cohort of men who underwent angiography.

More on Relation of erectile dysfunction to coronary artery disease

• Comment

Are the drugs effective for erectile dysfunction?

Presumably, each and every one knows what Viagra is for and the biggest hurdle, according to the who addressed a recent conference, is to get men to ask for a drug. Erectile dysfunction, which used to be called weakness, is indistinct as the inability to maintain an formation long sufficient for vaginal intercourse.

Though the ads have become ever more persistent in the five years since Viagra was approved, the drug obviously isn’t prearranged plentiful, numerous doctors told the science playwright’s conference on Sexual Dysfunction, held last month in New York and funded by a number of drug companies (Viagra’s producer, Pfizer, was not among them). Erectile dysfunction affects about 30% of all men, reporters were educated, and less than 1% are Viagra.

More on Are the drugs effective for erectile dysfunction?

• Comment

The Little Blue Erectile Dysfunction Pill

Viagra, the tiny blue pill that has not only been a voluptuous benefit to — according to manufacturer Pfizer’s number crunching — more than 16 zillion men, but has become nobody less than a key of American common culture.

It was five an inordinate length of time ago this month that Viagra received its stiff U.S. Food and Drug Administration approval.

More on The Little Blue Erectile Dysfunction Pill

• Comment

Levitra marketers don’t like Viagra

Levitra is the newest medication for erectile dysfunction, and men for whom Viagra doesn’t do the trick are enthusiastically seeking doctors’ of the new drug.

By year’s end, a oral drug for erectile dysfunction is foreseeable to hit the fair, which only can develop as baby-boom guys happenstance the plumbing hitches of moderate age and beyond.

More on Levitra marketers don’t like Viagra

• Comment

Cialis - new spin on battle in erectile dysfunction

Cialis main selling central theme is that it the whole kit and caboodle for 24 hours to 36 hours. It has assistance at the starting gate, too, with some men journalism movement at 16 record after , as with Levitra. Most, though, say the drug going on for 30 transcript to work.

Cialis had 30 of unit bit in Germany, by 27 percent in France, and 21 percent in Italy, in the UK, Cialis has gained 13 cut of units. In countries where Lilly has rights to market Cialis, the product had 33 of unit portion in Australia and 20 percent in Brazil.

More on Cialis - new spin on battle in erectile dysfunction

• Comment

Viagra has moved out into the popular culture

Some Viagra wives now have to challenge their own sexual dysfunction, sex experts say. Their husbands feel free to pack blue diamonds when they go on corporate . Erectile dysfunction (ED) — the incapability to get and insist an formation firm sufficient to have sex — no haunts them as it does 30 mountain American men.

And as Viagra goes mainstream, used by ever-younger men seeking self-confidence or bigger rather than relief from firmly medical situation, the results are showing up in split-up across the country.

More on Viagra has moved out into the popular culture

• Comment

Cardiovascular Disease and Erectile Dysfunction

Preliminary findings from clinicians at the Research Institute of the McGill University Health Centre (MUHC), show that men with dysfunction are more probable to have cardiovascular disease. Cardiovascular disease affects around 40 000 Canadian men annually.
“Our training suggests, that erectile dysfunction, principally in young men, may be an premature cautionary sign of heart disease and caress,” says MUHC Director of Clinical Epidemiology and lead agent, Dr. Steven Grover.

More on Cardiovascular Disease and Erectile Dysfunction

• Comment

Levitra approved by FDA

levitra.jpgThe Levitra is in the same intimate as Viagra. Both work by an imperative for maintaining an erection. The Food and Drug Administration approved Levitra on Tuesday.

Until now, the blue, equilateral-shaped Viagra pills have been the only oral prescription drug offered for an valued 30 million men in the USA who writhe some intensity of inability. Most don’t seek medical treatment.

Levitra, made by Bayer AG (BAY) and by GlaxoSmithKline (GSK), only just began selling in Europe. A third impotence pill — Cialis, from Eli Lilly (LLY) and Icos (ICOS)— also has European esteem and is awaited to hit U.S. pharmacies later this year.

More on Levitra approved by FDA

• Comment

Cialis make incursions against Viagra

Cialis, Eli Lilly and Co.’s way out to Viagra, has gained up to one-third of the erectile dysfunction market in where it is approved for sale.

The drug has 33 percent of the market in Australia, 30 in Germany and 27 in France, Lilly ICOS LLC said Aug. 19. The company is a joint venture between Indianapolis-based Lilly and Bothell, Wash.- ICOS Corp.

More on Cialis make incursions against Viagra

• Comment

Faces Competition for Viagra

While Viagra brought the production of erectile dysfunction into the freely available eye, the new drugs promise to take the discussion further and make it far more particular. The makers of one drug have told physicians at that men say the drug gave them more steadfast erections than Viagra, as the power of the other is such that it has even now been nicknamed “the holidaymaker.”
The fabricator of Viagra, Pfizer Inc., lost its cartel on such Tuesday when the Food and Drug Administration agreed Levitra, made by Bayer AG and GlaxoSmithKline PLC. The support is predictable to act later this year on the usage for Cialis, made by a interest of Eli Lilly and Co. and Icos Corp. Both drugs have been widely marketed abroad and are competing with some success against the creator.

“This wilderness is all about prime, and new add greatly to those ,” said Irwin Goldstein of the Center for Sexual Medicine at Boston University. “I can see men using one drug during the week when they want a shorter duration and a new on the visit for duration. . . . We can buy 86 discrete kinds of cars and so many not the same hypertensives and , so why should there be only one drug for ?”

More on Faces Competition for Viagra

• Comment